CHICAGO – August 1, 2019 – SonarMD, a care coordination and therapeutic optimization solution for high-beta conditions, will now have its founder serving full time as a member of its leadership team. After a 35-year successful career as a gastroenterologist, Lawrence R. Kosinski, MD, MBA, will now focus his energies exclusively on fulfilling SonarMD’s mission: to make value-based care a reality for patients with high-beta conditions. “We are excited to have Dr. Kosinski as a full-time member of our leadership team,” said Devin Gross, CEO, SonarMD. “His commitment to patients and the success of SonarMD is palpable throughout the office.” Dr. Kosinski founded SonarMD in 2014 and now serves as its chief medical officer. In this role, he is focused on defining clinical protocols, working with leaders at client and partner sites, and promoting thought leadership. “I had a long and wonderful career practicing medicine,” said Dr. Kosinski. “I bring every encounter with every patient, nurse and fellow specialist with me to this role. I am now honored to have the full-time opportunity to focus on making value-based care a reality for patients with high-beta conditions.” Dr. Kosinski has been in the practice of gastroenterology since 1984 and has been a leading clinician and researcher in the specialty for many years. He served as one of the managing partners of the Illinois Gastroenterology Group prior to his retirement in June 2019 (the month before its partnership with GI Alliance). Dr. Kosinski also recently completed a three-year term on the governing board of the American Gastroenterological Association. He is currently on the Advocate Sherman Hospital board of directors.